Longevity Lab Report
← All supplements

Thiamine (Vitamin B1)

Essential and cheap; the deficiency is dangerous, the supplement claims for the replete are empty.

C-

Evidence grade

C

Worth it

$5-10/month

Typical cost

DoseThe daily requirement is about 1.1 to 1.2 mg. Retail thiamine products commonly carry 50 to 100 mg, and the fat-soluble derivative benfotiamine is sold and studied at 150 to 600 mg/day. No dose is established for healthy adults, because no benefit in healthy adults has been established at any dose. Suspected deficiency is a medical problem: Wernicke's is treated with high-dose intravenous thiamine, not a capsule from a shelf.

BasisThiamine is an essential vitamin whose deficiency is genuinely dangerous, and almost everything beyond that sentence is thin.

Thiamine is the B1 vitamin, a cofactor in carbohydrate energy metabolism. We grade Thiamine (Vitamin B1) C- on evidence and C for worth-it at about $5-10 per month.

What it does

Thiamine is the B1 vitamin, a cofactor in carbohydrate energy metabolism. Deficiency causes beriberi and Wernicke's encephalopathy and is a medical emergency; supplementation in people who already get enough has no demonstrated outcome benefit.

What the research says

  • Treats and prevents thiamine deficiency, which is dangerous and sometimes fatal

    Evidence: strong. Deficiency causes beriberi and Wernicke-Korsakoff syndrome. Risk concentrates in alcohol use disorder, malnutrition, bariatric surgery, and severe vomiting. Treatment is urgent, clinical, and established; that is a medical use, not a wellness one.

  • No benefit for heart failure beyond correcting deficiency

    Evidence: moderate. The largest meta-analysis (7 randomized trials, 274 patients) found no significant effect on ejection fraction, walking distance, NT-proBNP, or symptom class. An earlier two-trial pooling (38 patients) reported a small ejection fraction gain; the bigger synthesis supersedes it.

  • Benfotiamine may slow cognitive decline in early Alzheimer's disease or MCI

    Evidence: emerging. One phase IIa trial (Gibson et al., 2020; 70 participants, 12 months, 300 mg twice daily): the primary cognitive outcome missed significance (ADAS-Cog decline 43 percent lower, p=0.125); a secondary rating improved (p=0.034). A pilot signal awaiting a real trial.

  • Studied for diabetic nerve pain with mixed results

    Evidence: weak. Benfotiamine trials in diabetic peripheral neuropathy split between short-term positives and longer nulls. Nothing here is settled in either direction.

Thiamine is an essential vitamin whose deficiency is genuinely dangerous, and almost everything beyond that sentence is thin. The heart-failure literature, the most-tested supplement claim, pools to no benefit beyond correcting deficiency. The benfotiamine cognitive pilot is one small trial whose primary outcome missed. The diabetic-neuropathy trials are mixed and small. For a generally nourished adult, there is no outcome evidence at any dose, and the vitamin's excellent safety record is a reason it is harmless to take, not a reason it helps.

What the experts say

Every position links to its source. We include skeptics alongside supporters.

  • Bryan Johnson

    Listed in the Blueprint stack as vitamin B1 (thiamine); basis takes, per the expert record.

Is it worth it?

CWorth it

Evidence (C-) sits below the evidence bar for the ranking, so the worth-it grade is capped at C+ however inexpensive it is; the derived value lands at C. About $7 a month at a common dose.

Typical cost

$5-10/month

Common form, not a brand recommendation

Dosage context established

The daily requirement is about 1.1 to 1.2 mg. Retail thiamine products commonly carry 50 to 100 mg, and the fat-soluble derivative benfotiamine is sold and studied at 150 to 600 mg/day. No dose is established for healthy adults, because no benefit in healthy adults has been established at any dose. Suspected deficiency is a medical problem: Wernicke's is treated with high-dose intravenous thiamine, not a capsule from a shelf.

The worth-it ranking

Thiamine (Vitamin B1) sits outside the worth-it ranking of 38.

Thiamine (Vitamin B1) sits outside that ranking of 38. The leaders below clear an evidence floor of B- before price counts at all, so cheap alone never earns a rank.

  1. 1AWorth itCreatine evidence A-~$5-10/mo
  2. 2AWorth itCaffeine evidence B+~$5-10/mo
  3. 3AWorth itVitamin D evidence B~$5-8/mo

See the full ranking of 38 →

When the evidence moves a grade, this ranking moves with it. Thursday is where you hear it first.

Safety notes

Oral thiamine has an excellent safety record at standard doses; no tolerable upper limit is set because toxicity from oral intake is not documented. Anaphylaxis is a rare parenteral-route event, not an oral supplement finding.

Changelog

Last updated 2026-11-18

  • 2026-11-15|Graded: deficiency correction credited as established medicine; replete-adult claims graded unsupported.
  • 2026-11-18|Update: this record now consolidates the library's two thiamine entries into one. The evidence review behind it reads the heart-failure trials as showing no benefit beyond correcting deficiency, and the grade reflects supplementation for adults who are not deficient.

The week's longevity and biohacking news.

Every story graded against the evidence. Free. Unsubscribe anytime.

The week's longevity and biohacking news. Every story graded against the evidence. Free. Unsubscribe anytime.

Every grade follows a published rubric. Sponsors do not influence findings or grades.